Inflammasomes in the CNS

Nature Reviews Neuroscience

Volumn 15, Issue 2, 2014, Pages 84-97

  Walsh, John G ^a   Muruve, Daniel A ^b   Power, Christopher ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CRYOPYRIN; INFLAMMASOME;

ACUTE BRAIN DISEASE; BRAIN INFECTION; BRAIN INJURY; CELL DEATH; CENTRAL NERVOUS SYSTEM; CHRONIC BRAIN DISEASE; CONTROLLED STUDY; HUMAN; IMMUNOREACTIVITY; INNATE IMMUNITY; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; INFLAMMASOMES; MACROPHAGES; NERVOUS SYSTEM DISEASES; NEUROGLIA;

EID: 84892795119     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn3638     Document Type: Review

References (148)

1. Ransohoff, R. M. & Brown, M. A. Innate immunity in the central nervous system. J. Clin. Invest. 122, 1164-1171 (2012).
2. Glass, C. K. , Saijo, K. , Winner, B. , Marchetto, M. C. & Gage, F. H. Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918-934 (2010).
3. Allan, S. M. & Rothwell, N. J. Cytokines and acute neurodegeneration. Nature Rev. Neurosci. 2, 734-744 (2001).
4. Martinon, F. , Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-?. Mol. Cell 10, 417-426 (2002). This article coined the term 'inflammasome' and described the complex for the first time.
5. Rathinam, V. A. , Vanaja, S. K. & Fitzgerald, K. A. Regulation of inflammasome signaling. Nature Immunol. 13, 333-342 (2012).
6. Agostini, L. et al. NALP3 forms an IL-1?-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20, 319-325 (2004).
7. Minkiewicz, J. , de Rivero Vaccari, J. P. & Keane, R. W. Human astrocytes express a novel NLRP2 inflammasome. Glia 61, 1113-1121 (2013).
8. Fernandes-Alnemri, T. , Yu, J. W. , Datta, P. , Wu, J. & Alnemri, E. S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509-513 (2009).
9. Faustin, B. et al. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 25, 713-724 (2007).
10. Case, C. L. & Roy, C. R. Asc modulates the function of NLRC4 in response to infection of macrophages by Legionella pneumophila. mBio 2, e00117-11 (2011).
11. Franchi, L. , Munoz-Planillo, R. & Nunez, G. Sensing and reacting to microbes through the inflammasomes. Nature Immunol. 13, 325-332 (2012).
12. Allan, S. M. , Tyrrell, P. J. & Rothwell, N. J. Interleukin-1 and neuronal injury. Nature Rev. Immunol. 5, 629-640 (2005).
13. Alboni, S. , Cervia, D. , Sugama, S. & Conti, B. Interleukin 18 in the CNS. J. Neuroinflammation 7, 9 (2010).
14. John, G. R. , Lee, S. C. , Song, X. , Rivieccio, M. & Brosnan, C. F. IL-1-regulated responses in astrocytes: relevance to injury and recovery. Glia 49, 161-176 (2005).
15. Bergsbaken, T. , Fink, S. L. & Cookson, B. T. Pyroptosis: host cell death and inflammation. Nature Rev. Microbiol. 7, 99-109 (2009).
16. Zhang, W. H. et al. Fundamental role of the Rip2/ caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death. Proc. Natl Acad. Sci. USA 100, 16012-16017 (2003). This study provides strong evidence for a caspase 1-dependent cell death pathway that is localized in neurons, using caspase 1-knockout mice.
17. de Rivero Vaccari, J. P. , Lotocki, G. , Marcillo, A. E. , Dietrich, W. D. & Keane, R. W. A molecular platform in neurons regulates inflammation after spinal cord injury. J. Neurosci. 28, 3404-3414 (2008).
18. de Rivero Vaccari, J. P. et al. Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J. Cereb. Blood Flow Metab. 29, 1251-1261 (2009). One of several related studies to propose a novel role for NLRP1 activation in the response to acute brain injury.
19. Silverman, W. R. et al. The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J. Biol. Chem. 284, 18143-18151 (2009).
20. Wu, J. , Fernandes-Alnemri, T. & Alnemri, E. S. Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by Listeria monocytogenes. J. Clin. Immunol. 30, 693-702 (2010).
21. Jamilloux, Y. et al. Inflammasome activation restricts Legionella pneumophila replication in primary microglial cells through flagellin detection. Glia 61, 539-549 (2013).
22. Miao, E. A. et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1? via Ipaf. Nature Immunol. 7, 569-575 (2006).
23. Miao, E. A. et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl Acad. Sci. USA 107, 3076-3080 (2010).
24. Kofoed, E. M. & Vance, R. E. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 477, 592-595 (2011).
25. Zhao, Y. et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477, 596-600 (2011).
26. Vinzing, M. et al. NAIP and Ipaf control Legionella pneumophila replication in human cells. J. Immunol. 180, 6808-6815 (2008).
27. Maier, J. K. et al. The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7. J. Neurosci. 22, 2035-2043 (2002).
28. Boyden, E. D. & Dietrich, W. F. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nature Genet. 38, 240-244 (2006).
29. Moayeri, M. , Sastalla, I. & Leppla, S. H. Anthrax and the inflammasome. Microbes Infect. 14, 392-400 (2012).
30. Finger, J. N. et al. Autolytic proteolysis within the function to find domain (FIIND) is required for NLRP1 inflammasome activity. J. Biol. Chem. 287, 25030-25037 (2012).
31. Ebrahimi, C. M. , Sheen, T. R. , Renken, C. W. , Gottlieb, R. A. & Doran, K. S. Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis. Infect. Immun. 79, 2510-2518 (2011).
32. Fink, S. L. , Bergsbaken, T. & Cookson, B. T. Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Proc. Natl Acad. Sci. USA 105, 4312-4317 (2008).
33. Levinsohn, J. L. et al. Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome. PLoS Pathog. 8, e1002638 (2012).
34. D'Osualdo, A. et al. CARD8 and NLRP1 undergo autoproteolytic processing through a ZU5-like domain. PLoS ONE 6, e27396 (2011).
35. Geldhoff, M. et al. Genetic variation in inflammasome genes is associated with outcome in bacterial meningitis. Immunogenetics 65, 9-16 (2013).
36. Bruey, J. M. et al. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 129, 45-56 (2007).
37. Deveraux, Q. L. et al. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J. 18, 5242-5251 (1999).
38. Labbe, K. , McIntire, C. R. , Doiron, K. , Leblanc, P. M. & Saleh, M. Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome. Immunity 35, 897-907 (2011).
39. Vince, J. E. et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 36, 215-227 (2012).
40. Pelegrin, P. & Surprenant, A. Pannexin-1 mediates large pore formation and interleukin-1? release by the ATP-gated P2X7 receptor. EMBO J. 25, 5071-5082 (2006).
41. Karatas, H. et al. Spreading depression triggers headache by activating neuronal Panx1 channels. Science 339, 1092-1095 (2013).
42. Qu, Y. et al. Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. J. Immunol. 186, 6553-6561 (2011).
43. Bargiotas, P. , Krenz, A. , Monyer, H. & Schwaninger, M. Functional outcome of pannexin-deficient mice after cerebral ischemia. Channels (Austin) 6, 453-456 (2012).
44. Hanstein, R. et al. Promises and pitfalls of a Pannexin1 transgenic mouse line. Front. Pharmacol. 4, 61 (2013).
45. MacVicar, B. A. & Thompson, R. J. Non-junction functions of pannexin-1 channels. Trends Neurosci. 33, 93-102 (2010).
46. Pontillo, A. , Catamo, E. , Arosio, B. , Mari, D. & Crovella, S. NALP1/NLRP1 genetic variants are associated with Alzheimer disease. Alzheimer Dis. Assoc. Disord. 26, 277-281 (2012).
47. Duncan, J. A. et al. Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J. Immunol. 182, 6460-6469 (2009).
48. Ichinohe, T. , Lee, H. K. , Ogura, Y. , Flavell, R. & Iwasaki, A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206, 79-87 (2009).
49. Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232 (2006).
50. Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-?. Nature Immunol. 9, 857-865 (2008). The first study to implicate inflammasome activation in response to a misfolded protein - in this case, amyloid-?.
51. Martinon, F. , Petrilli, V. , Mayor, A. , Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241 (2006).
52. Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nature Immunol. 9, 847-856 (2008).
53. Bauernfeind, F. G. et al. Cutting edge: NF-?B activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183, 787-791 (2009).
54. Ferrari, D. et al. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159, 1451-1458 (1997).
55. Piccini, A. et al. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1? and IL-18 secretion in an autocrine way. Proc. Natl Acad. Sci. USA 105, 8067-8072 (2008).
56. Petrilli, V. et al. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14, 1583-1589 (2007).
57. Munoz-Planillo, R. et al. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38, 1142-1153 (2013). This study reports that all activators of the NLRP3 inflammasome mediate their actions through the triggering of a K+ efflux.
58. Schorn, C. et al. Sodium overload and water influx activate the NALP3 inflammasome. J. Biol. Chem. 286, 35-41 (2011).
59. Compan, V. et al. Cell volume regulation modulates NLRP3 inflammasome activation. Immunity 37, 487-500 (2012). A recent study that proposes cell volume changes as a conserved mechanism for regulating NLRP3 inflammasome activation, including within neurons.
60. Chu, J. et al. Cholesterol-dependent cytolysins induce rapid release of mature IL-1? from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner. J. Leukoc. Biol. 86, 1227-1238 (2009).
61. Zaiss, A. K. et al. Antiviral antibodies target adenovirus to phagolysosomes and amplify the innate immune response. J. Immunol. 182, 7058-7068 (2009).
62. Hoegen, T. et al. The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release. J. Immunol. 187, 5440-5451 (2011). This study shows that NLPR3 activation promotes brain injury in pneumococcal meningitis. This contrasts with pneumococcal pneumonia, in which NLRP3 inflammasome activation is protective.
63. Codolo, G. et al. Triggering of inflammasome by aggregated ?-synuclein, an inflammatory response in synucleinopathies. PLoS ONE 8, e55375 (2013).
64. Dostert, C. et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674-677 (2008).
65. Cruz, C. M. et al. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 282, 2871-2879 (2007).
66. Zhou, R. , Tardivel, A. , Thorens, B. , Choi, I. & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nature Immunol. 11, 136-140 (2010).
67. Kaushik, D. K. , Gupta, M. , Kumawat, K. L. & Basu, A. NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis. PLoS ONE 7, e32270 (2012).
68. Masters, S. L. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1? in type 2 diabetes. Nature Immunol. 11, 897-904 (2010).
69. Nakahira, K. et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nature Immunol. 12, 222-230 (2011).
70. Zhou, R. , Yazdi, A. S. , Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221-225 (2011).
71. Shimada, K. et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36, 401-414 (2012).
72. Subramanian, N. , Natarajan, K. , Clatworthy, M. R. , Wang, Z. & Germain, R. N. The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell 153, 348-361 (2013).
73. Ramos, H. J. et al. IL-1? signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog. 8, e1003039 (2012). This study demonstrates a role for an inflammasome-dependent protective response during encephalitis caused by WNV.
74. Burguillos, M. A. et al. Caspase signalling controls microglia activation and neurotoxicity. Nature 472, 319-324 (2011).
75. Shi, F. et al. The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation. J. Neuroinflammation 9, 73 (2012).
76. Hanamsagar, R. , Torres, V. & Kielian, T. Inflammasome activation and IL-1?/IL-18 processing are influenced by distinct pathways in microglia. J. Neurochem. 119, 736-748 (2011).
77. Gulbransen, B. D. et al. Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nature Med. 18, 600-604 (2012).
78. Kone-Paut, I. & Piram, M. Targeting interleukin-1? in CAPS (cryopyrin-associated periodic) syndromes: what did we learn? Autoimmun. Rev. 12, 77-80 (2012).
79. Rathinam, V. A. et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nature Immunol. 11, 395-402 (2010).
80. Jin, T. et al. Structures of the HIN domain: DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity 36, 561-571 (2012).
81. Kummer, J. A. et al. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J. Histochem. Cytochem. 55, 443-452 (2007).
82. Yin, Y. et al. Inflammasomes are differentially expressed in cardiovascular and other tissues. Int. J. Immunopathol. Pharmacol. 22, 311-322 (2009).
83. Guarda, G. et al. Differential expression of NLRP3 among hematopoietic cells. J. Immunol. 186, 2529-2534 (2011).
84. Tarallo, V. et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 149, 847-859 (2012).
85. Miggin, S. M. et al. NF-?B activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1. Proc. Natl Acad. Sci. USA 104, 3372-3377 (2007).
86. Agard, N. J. , Maltby, D. & Wells, J. A. Inflammatory stimuli regulate caspase substrate profiles. Mol. Cell. Proteomics 9, 880-893 (2010).
87. Griffin, W. S. et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl Acad. Sci. USA 86, 7611-7615 (1989).
88. McGuinness, M. C. et al. Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis. J. Neuroimmunol. 75, 174-182 (1997).
89. Zaremba, J. & Losy, J. Interleukin-18 in acute ischaemic stroke patients. Neurol. Sci. 24, 117-124 (2003).
90. Taylor, R. C. , Cullen, S. P. & Martin, S. J. Apoptosis: controlled demolition at the cellular level. Nature Rev. Mol. Cell Biol. 9, 231-241 (2008).
91. Lightfield, K. L. et al. Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nature Immunol. 9, 1171-1178 (2008).
92. Lee, H. M. et al. Mycobacterium abscessus activates the NLRP3 inflammasome via Dectin-1-Syk and p62/SQSTM1. Immunol. Cell Biol. 90, 601-610 (2012).
93. Soong, G. , Chun, J. , Parker, D. & Prince, A. Staphylococcus aureus activation of caspase 1/ calpain signaling mediates invasion through human keratinocytes. J. Infect. Dis. 205, 1571-1579 (2012).
94. Chien, H. & Dix, R. D. Evidence for multiple cell death pathways during development of experimental cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression: apoptosis, necroptosis, and pyroptosis. J. Virol. 86, 10961-10978 (2012).
95. Troy, C. M. , Stefanis, L. , Prochiantz, A. , Greene, L. A. & Shelanski, M. L. The contrasting roles of ICE family proteases and interleukin-1? in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation. Proc. Natl Acad. Sci. USA 93, 5635-5640 (1996).
96. Guegan, C. et al. Instrumental activation of bid by caspase-1 in a transgenic mouse model of ALS. Mol. Cell. Neurosci. 20, 553-562 (2002).
97. Friedlander, R. M. et al. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J. Exp. Med. 185, 933-940 (1997).
98. Mehta, A. , Prabhakar, M. , Kumar, P. , Deshmukh, R. & Sharma, P. L. Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur. J. Pharmacol. 698, 6-18 (2013).
99. McNeela, E. A. et al. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog. 6, e1001191 (2010).
100. Mitchell, A. J. et al. Inflammasome-dependent IFN-? drives pathogenesis in Streptococcus pneumoniae meningitis. J. Immunol. 189, 4970-4980 (2012).
101. Zwijnenburg, P. J. et al. Interleukin-18 gene-deficient mice show enhanced defense and reduced inflammation during pneumococcal meningitis. J. Neuroimmunol. 138, 31-37 (2003).
102. Lee, H. M. , Kang, J. , Lee, S. J. & Jo, E. K. Microglial activation of the NLRP3 inflammasome by the priming signals derived from macrophages infected with mycobacteria. Glia 61, 441-452 (2013).
103. Kumar, M. et al. Inflammasome adaptor protein apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in West Nile virus encephalitis. J. Virol. 87, 3655-3667 (2013).
104. Mori, I. et al. Impaired microglial activation in the brain of IL-18-gene-disrupted mice after neurovirulent influenza A virus infection. Virology 287, 163-170 (2001).
105. Sergerie, Y. , Rivest, S. & Boivin, G. Tumor necrosis factor-? and interleukin-1? play a critical role in the resistance against lethal herpes simplex virus encephalitis. J. Infect. Dis. 196, 853-860 (2007).
106. Schielke, G. P. , Yang, G. Y. , Shivers, B. D. & Betz, A. L. Reduced ischemic brain injury in interleukin-1? converting enzyme-deficient mice. J. Cereb. Blood Flow Metab. 18, 180-185 (1998).
107. Wheeler, R. D. et al. No role for interleukin-18 in acute murine stroke-induced brain injury. J. Cereb. Blood Flow Metab. 23, 531-535 (2003).
108. Pradillo, J. M. et al. Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats. J. Cereb. Blood Flow Metab. 32, 1810-1819 (2012).
109. Boutin, H. et al. Role of IL-1? and IL-1? in ischemic brain damage. J. Neurosci. 21, 5528-5534 (2001).
110. Afonina, I. S. et al. Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1?. Mol. Cell 44, 265-278 (2011).
111. Zheng, Y. , Humphry, M. , Maguire, J. J. , Bennett, M. R. & Clarke, M. C. Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1?, controlling necrosis-induced sterile inflammation. Immunity 38, 285-295 (2013).
112. Keller, M. , Ruegg, A. , Werner, S. & Beer, H. D. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132, 818-831 (2008).
113. Abulafia, D. P. et al. Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. J. Cereb. Blood Flow Metab. 29, 534-544 (2009).
114. Frederick Lo, C. , Ning, X. , Gonzales, C. & Ozenberger, B. A. Induced expression of death domain genes NALP1 and NALP5 following neuronal injury. Biochem. Biophys. Res. Commun. 366, 664-669 (2008).
115. Adamczak, S. et al. Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article. J. Neurosurg. 117, 1119-1125 (2012).
116. Gris, D. et al. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J. Immunol. 185, 974-981 (2010).
117. Inoue, M. , Williams, K. L. , Gunn, M. D. & Shinohara, M. L. NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 109, 10480-10485 (2012).
118. Lalor, S. J. et al. Caspase-1-processed cytokines IL-1? and IL-18 promote IL-17 production by and CD4 T cells that mediate autoimmunity. J. Immunol. 186, 5738-5748 (2011).
119. Jha, S. et al. The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J. Neurosci. 30, 15811-15820 (2010). This study shows that mice deficient in a particular inflammasome or caspase 1 activation pathway exhibit less neurological disease owing to an ameliorated inflammatory response.
120. Mason, J. L. , Suzuki, K. , Chaplin, D. D. & Matsushima, G. K. Interleukin-1? promotes repair of the CNS. J. Neurosci. 21, 7046-7052 (2001).
121. Meissner, F. , Molawi, K. & Zychlinsky, A. Mutant superoxide dismutase 1-induced IL-1? accelerates ALS pathogenesis. Proc. Natl Acad. Sci. USA 107, 13046-13050 (2010). This study demonstrates that inflammasome activation in response to SOD1 enhances pathogenesis in an ALS model.
122. Craft, J. M. , Watterson, D. M. , Hirsch, E. & Van Eldik, L. J. Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human ?-amyloid. J. Neuroinflammation 2, 15 (2005).
123. Shaftel, S. S. et al. Sustained hippocampal IL-1? overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J. Clin. Invest. 117, 1595-1604 (2007).
124. Heneka, M. T. et al. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493, 674-678 (2013). This study shows that NLRP3 inflammasome activation adversely affects disease outcome in a mouse model of Alzheimer's disease.
125. Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757 (2011).
126. Vladimer, G. I. et al. The NLRP12 inflammasome recognizes Yersinia pestis. Immunity 37, 96-107 (2012).
127. Akhter, A. et al. Caspase-11 promotes the fusion of phagosomes harboring pathogenic bacteria with lysosomes by modulating actin polymerization. Immunity 37, 35-47 (2012).
128. Broz, P. et al. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 490, 288-291 (2012).
129. Rathinam, V. A. et al. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by Gram-negative bacteria. Cell 150, 606-619 (2012).
130. von Moltke, J. et al. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 490, 107-111 (2012).
131. Lu, J. X. et al. Molecular structure of ?-amyloid fibrils in Alzheimer's disease brain tissue. Cell 154, 1257-1268 (2013).
132. Yang, E. J. , Kim, S. , Kim, J. S. & Choi, I. H. Inflammasome formation and IL-1? release by human blood monocytes in response to silver nanoparticles. Biomaterials 33, 6858-6867 (2012).
133. Liao, Y. H. et al. HMG-CoA reductase inhibitors activate caspase-1 in human monocytes depending on ATP release and P2X7 activation. J. Leukoc. Biol. 93, 289-299 (2013).
134. Ruperto, N. et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N. Engl. J. Med. 367, 2396-2406 (2012).
135. Lamkanfi, M. et al. Glyburide inhibits the Cryopyrin/ Nalp3 inflammasome. J. Cell Biol. 187, 61-70 (2009).
136. Coll, R. C. & O'Neill, L. A. The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes. PLoS ONE 6, e29539 (2011).
137. Deroide, N. et al. MFGE8 inhibits inflammasome-induced IL-1? production and limits postischemic cerebral injury. J. Clin. Invest. 123, 1176-1181 (2013).
138. Yan, Y. et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38, 1154-1163 (2013).
139. Prinz, M. , Priller, J. , Sisodia, S. S. & Ransohoff, R. M. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nature Neurosci. 14, 1227-1235 (2011).
140. Czirr, E. & Wyss-Coray, T. The immunology of neurodegeneration. J. Clin. Invest. 122, 1156-1163 (2012).
141. Hyman, B. T. & Yuan, J. Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology. Nature Rev. Neurosci. 13, 395-406 (2012).
142. Kaczmarek, A. , Vandenabeele, P. & Krysko, D. V. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38, 209-223 (2013).
143. Chavez-Valdez, R. , Martin, L. J. , Flock, D. L. & Northington, F. J. Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia. Neuroscience 219, 192-203 (2012).
144. Li, Z. et al. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 141, 859-871 (2010).
145. Graham, R. K. , Ehrnhoefer, D. E. & Hayden, M. R. Caspase-6 and neurodegeneration. Trends Neurosci. 34, 646-656 (2011).
146. Dostert, C. et al. Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS ONE 4, e6510 (2009).
147. Reimer, T. et al. Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome. Eur. J. Immunol. 40, 764-769 (2010).
148. Hafner-Bratkovic, I. , Bencina, M. , Fitzgerald, K. A. , Golenbock, D. & Jerala, R. NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL1? and neuronal toxicity. Cell. Mol. Life Sci. 69, 4215-4228 (2012).